These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3356536)

  • 1. Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.
    Keret R; Pertzelan A; Zeharia A; Zadik Z; Laron Z
    Isr J Med Sci; 1988 Feb; 24(2):75-9. PubMed ID: 3356536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.
    Eshet R; Laron Z; Pertzelan A; Arnon R; Dintzman M
    Isr J Med Sci; 1984 Jan; 20(1):8-11. PubMed ID: 6321400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronobiological pattern of growth hormone secretion in normal subjects and in retinopathic diabetics. Lack of suppression by a plurichronocorticoid drug.
    Muggeo M; Molinari M; Baiocchi A; Tiengo A; Fedele D; Crepaldi G
    Chronobiologia; 1976; 3(4):323-34. PubMed ID: 1030662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity and non-linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation.
    Ilias I; Vgontzas AN; Provata A; Mastorakos G
    Endocr Regul; 2002 Jun; 36(2):63-72. PubMed ID: 12207555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic clearance and production rates of human growth hormone.
    Taylor AL; Finster JL; Mintz DH
    J Clin Invest; 1969 Dec; 48(12):2349-58. PubMed ID: 5355346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy of Octreotide LAR in the treatment of acromegaly--a yearly observation].
    Bałdys-Waligórska A; Gołkowski F; Krzentowska A; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(5):218-21. PubMed ID: 19739577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.
    Thompson RG; Rodriguez A; Kowarski A; Blizzard RM
    J Clin Invest; 1972 Dec; 51(12):3193-9. PubMed ID: 4640954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
    J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.
    Eshet R; Peleg S; Josefsberg Z; Fuchs C; Arnon R; Laron Z
    Horm Res; 1985; 22(4):276-83. PubMed ID: 3000911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of human growth hormone circadian rhythm in patients with homozygous beta-thalassemia.
    Pasqualetti P; Collacciani A; Natali GF; Colantonio D; Casale R
    Panminerva Med; 1992; 34(3):124-7. PubMed ID: 1491871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-active growth hormone in Laron dwarfism.
    Jacobs LS; Sneid DS; Garland JT; Laron Z; Daughaday WH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):403-6. PubMed ID: 177445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variation of basal plasma growth hormone in man.
    Drobny EC; Amburn K; Baumann G
    J Clin Endocrinol Metab; 1983 Sep; 57(3):524-8. PubMed ID: 6348063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism.
    Sarnat H; Kaplan I; Pertzelan A; Laron Z
    Oral Surg Oral Med Oral Pathol; 1988 Nov; 66(5):581-6. PubMed ID: 3200561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance and insulin secretion in parents and children with familial dwarfism and high plasma immunoreactive growth hormone (IR-HGH) and familial isolated growth hormone deficiency.
    Karp M; Laron Z; Pertzelan A
    Horm Metab Res; 1972 Jul; 4(4):284-8. PubMed ID: 5086199
    [No Abstract]   [Full Text] [Related]  

  • 18. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.
    Christiansen JS; Orskov H; Binder C; Kastrup KW
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):6-10. PubMed ID: 6681687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.
    Schönberger W; Grimm W; Ziegler R
    Eur J Pediatr; 1977 Dec; 127(1):15-9. PubMed ID: 606555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory patterns of growth hormone during basal periods in man.
    Stolar MW; Baumann G
    Metabolism; 1986 Sep; 35(9):883-8. PubMed ID: 3747844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.